AscellaHealth

In the most recent episode of AscellaHealth Podcast Pulse, our featured guest, Mario, shared his compelling journey living with ITP since his initial diagnosis in 2014. Over the course of the discussion, Mario reflected on the significance of his relationship with Sean, a pharmacist and supporting member of his AscellaHealth Patient Care Team. Sean provided personalized support and guidance tailored to Mario’s unique needs and health challenges, giving him an elevated sense of confidence in his care plan. To learn more about Mario's inspiring decade-long journey living with ITP, we invite you to listen to the full podcast episode: https://lnkd.in/ewbMSd-k You can also read more about Mario’s journey in our latest Patient Voices article: https://lnkd.in/e3hPwKKT #AscellaHealth #AscellaHealthPodcastPulse #RareDiseases #RareDiseaseMonth #RareDiseaseAwareness #BloodDisorder #LifeSciences #PatientStory #PatientAdvocacy #Spotify 

In recognition of Rare Disease Awareness Month, we spotlighted Mario’s inspiring journey with Idiopathic Thrombocytopenia Purpura (ITP) in this short video snippet from AscellaHealth Podcast Pulse’s latest episode!    Living with rare disease comes with many challenges, but Mario’s story is one of positivity and resilience. In this clip, he shares how small steps and subtle mindset shifts helped him navigate the toughest moments of his journey. Instead of dwelling on setbacks, he focused on incremental progress—proving that focusing on the little things can lead to meaningful outcomes.    Listen to the full podcast episode to hear more of Mario’s incredible story and read the article to learn more: https://lnkd.in/eF9xqcd2   #AscellaHealth #AscellaHealthPodcastPulse #RareDiseases #RareDiseaseMonth #RareDiseaseAwareness #BloodDisorder #LifeSciences #PatientStory #PatientAdvocacy #Spotify

New Article + Podcast for Rare Disease Awareness Month! Living with rare disease comes with unique challenges, but the right support system can make all the difference. In honor of Rare Disease Awareness Month, AscellaHealth spoke with Mario about his decade-long journey with Idiopathic Thrombocytopenia Purpura (ITP) and the critical role of personalized patient care, pharmacist support, and maintaining a positive mindset in navigating treatment. Mario shares how AscellaHealth’s Patient Care Team provided expert guidance and compassionate support when he needed it most. His story is a powerful reminder of the impact personalized care can have in improving both the quality and efficiency of the patient journey for those facing rare diseases. Listen to the podcast and read the article: https://lnkd.in/eF9xqcd2 #AscellaHealth #RareDiseases #PatientCare #PharmacySupport #PatientAdvocacy #LifeSciences

Exciting news! Optime Care, an AscellaHealth company, is expanding its collaboration with Eton Pharmaceuticals to serve as the specialty pharmacy provider for GALZIN® (zinc acetate) —an FDA-approved treatment for Wilson Disease. Through this partnership, we continue our commitment to supporting patients with rare diseases by delivering tailored programs, personalized care, and comprehensive treatment support. Our dedicated teams work to improve access to vital therapies, enhance patient outcomes, and ensure financial assistance is available for those who need it most. Read more in our latest press release: https://lnkd.in/eAmmWvVk #EtonPharmaceuticals #WilsonDisease #SpecialtyPharmacy #PatientSupport #RareDiseases #HealthcareInnovation #GALZIN #Collaboration

As the U.S. healthcare system moves towards value-based care, payers and biopharmaceutical manufacturers are increasingly shifting from volume-based to value-based contracts (VBCs). These contracts focus on quality outcomes and cost efficiency, ensuring that compensation is tied to treatment success rather than volume. In AscellaHealth’s two-part series, Navigating the Value-Based Care Shift: Key Challenges for Payers, we explore the transition to VBCs in specialty therapies. In Part 1 of our series, we covered the key concepts and challenges faced by payers and manufacturers. In Part 2, we’ll explore value-based care models, payment approaches, and share real-world examples of how these innovative strategies are being successfully implemented. Read more here: https://lnkd.in/eQA2-3YU #ValueBasedCare #HealthcareInnovation #SpecialtyPharma #GeneTherapy #PharmaInsights #PayerSolutions #HealthcareAccess

New Podcast Episode!  In support of Rare Disease Awareness Month, our latest episode of AscellaHealth's Podcast Pulse features a compelling discussion with Mario, a rare disease patient living with Idiopathic Thrombocytopenia Purpura (ITP). Join Gabriella Patone, Host of AscellaHealth’s Podcast Pulse “Patient Voices: Beyond the Diagnosis” podcast series, as she speaks with Mario about navigating the challenges of this rare blood disorder. Mario graciously broaches a range of topics, including his initial diagnosis, managing the condition, its impact on his daily life and the strategies he employs to maintain a positive outlook throughout the treatment process. To learn more about Mario's inspiring decade-long journey with ITP, listen to the full episode here: https://lnkd.in/e6BjnCRP   #AscellaHealth #AscellaHealthPodcastPulse #RareDiseases #RareDiseaseMonth #RareDiseaseAwareness #IdiopathicThrombocytopeniaPurpura #BloodDisorder #LifeSciences #PatientStory #PatientAdvocacy #Spotify

Exciting Leadership Expansion at AscellaHealth! We are thrilled to announce the appointment of two new senior leaders to help accelerate our growth and strengthen operations. Clayton Edwards, RPh, MBA has been named Senior Vice President, Payer Business Unit, and Carl T. Bertram, PharmD, MS, MBA has been appointed Senior Vice President, Pharma Business Unit. These strategic roles will be crucial in driving performance, enhancing client and partner experiences, and supporting AscellaHealth’s mission to improve access to innovative therapies and clinical outcomes for individuals with rare and complex conditions. Read more in the press release: https://lnkd.in/ejpfiC3Z #Leadership #HealthcareInnovation #PatientCentricCare #AscellaHealth

Specialty drug innovation is accelerating, with new gene therapies, biosimilars, and targeted treatments reshaping the market. Andy Szczotka, Pharm.D., Chief Pharmacy Officer at AscellaHealth, was featured in Radar on Specialty Pharmacy discussing upcoming launches and three recently approved specialty drugs with the potential to significantly influence their respective therapeutic markets. As payers and providers navigate coverage challenges, staying ahead of these advancements is critical to optimizing access and cost management —ensuring patients receive the most effective and affordable treatments. A big thank you to MMIT (Managed Markets Insight & Technology) Network and Angela Maas for the feature! Read more about the latest specialty and rare disease pipeline trends: https://lnkd.in/e_shNZPf

Patients with rare diseases face significant barriers to accessing specialty treatments. At AscellaHealth, we work alongside global life science partners to break down those barriers and ensure timely access to care. In the latest episode of Podcast Pulse, Gillian Molloy, Global VP of Market Access, Alexis Moss, Director of Business Development EU/UK, and Jonathan Chapper, CEO of CHAPPER healthcare, explore how AscellaHealth and CHAPPER healthcare are uniquely positioned to meet the critical needs of rare disease patients around the world. Listen to the full episode: https://lnkd.in/e6BjnCRP #AscellaHealth #CHAPPERhealthcare #AscellaHealthPodcastPulse #RareDiseaseCare #SpecialtyPharmacy #LifeSciences #Spotify #GlobalHealth

Specialty drugs and advanced cell and gene therapies are expanding treatment possibilities for complex, chronic, and rare diseases. However, the rising costs associated with these therapies remain a major challenge for payers, as 74% of health plans and employers identified affordability as a key concern. In response, the value-based care model is emerging as a promising solution, striving to ensure a balance of both access and affordability. Discover how value-based care is reshaping healthcare in Part 1 of AscellaHealth's latest series, Navigating the Value-Based Care Shift: Key Challenges for Payers. Read more here: https://lnkd.in/eUaC5JF3 #ValueBasedCare #HealthcareInnovation #SpecialtyPharma #GeneTherapy #PharmaInsights #PayerSolutions #HealthcareAccess